Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Geloprep
- Development stage
- Phase 1
- Lead developer
- Zealand University Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Geloprep is a gel-based bowel preparation agent developed by Zealand University Hospital for colonic cleansing prior to colonoscopy or CT colonography. Formulated as an alternative to traditional large-volume liquid osmotic laxatives (such as Moviprep), Geloprep aims to improve patient adherence and tolerability by providing the cleansing agent in a gel format. It functions as an osmotic laxative, drawing water into the intestinal lumen to soften stool and induce bowel movements, thereby ensuring a clear colon for diagnostic visualization. The intervention is identified in clinical trials by the code 'A 06 ad', which corresponds to the ATC category for osmotically acting laxatives.
- Brand names
- Geloprep
- Other names
- Gel-based colon cleansing agent
Beyond the preview
Go deeper on Geloprep.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Geloprep.